Mr Uwe Braun, Product Manager Patient Compliance Monitoring Solutions
Europe 2019 (pdf) Presentation - IDTechEx*
If you already have access, please [Login]
Access is available via an IDTechEx Market Intelligence Subscription
• How to overcome challenges within manufacturing processes for smart blister packages
• Scaling up from manual to industrialized R2R manufacturing processes
• Printed and plasticized conductive lines for highly flexible and robust packages
• Benefits along the whole and expanded supply chain
Speaker Biography (Uwe Braun)
Uwe Braun is Product Manager for Patient Compliance Monitoring Solutions at Schreiner MediPharm, a business unit of Schreiner Group GmbH & Co. KG. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Uwe is in charge of developing new markets and printed electronics solutions for pharmaceuticals. He has been with the Schreiner Group since 1993, holding several positions in Sales, Product Management and Business Development for the pharmaceutical as well as automotive industry. He holds a degree in Printing Technology from the University of Applied Sciences Munich.
Company Profile (Schreiner MediPharm)
View Schreiner MediPharm Timeline
Schreiner MediPharm is a leader in the development and manufacture of innovative specialty labels with value-added benefits for the pharmaceutical and medical device industry. The product portfolio includes labels with integrated hangers, with detachable parts and multi-page labels. Additionally, the company offers syringe labels with integrated needle protection, anti-tampering and counterfeiting protection solutions as well as NFC/RFID labels and smart packaging solutions. These products simplify dispensing and administering of pharmaceuticals, enhance drug safety and clearly reduce process costs. Thanks to its strong solutions expertise and specialized know-how Schreiner MediPharm is a highly capable development partner and reliable quality supplier to leading pharmaceutical companies worldwide.